← FDA Drug Approvals (Drugs@FDA)

PAZOPANIB HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2024-12-04

Drug application

FDA Application #

ANDA219034

Application type

Abbreviated New Drug Application (Generic)

Brand name

PAZOPANIB HYDROCHLORIDE

Generic name

PAZOPANIB

Active ingredients

PAZOPANIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2024-12-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown